Table 3.
Group | TPF (%) | FP/case | DC (%) | JI (%) | VER (%) | ASD (mm) | TBE (%) |
---|---|---|---|---|---|---|---|
79 tumors (n=14 ) | 100.0 | 3.1 | 74.1±16.9 | 70.9±17.7 | 12.4±12.0 | 1.6±1.5 | 0.9±1.0 |
10 MICCAI tumors (n=4) | -- | -- | 75.4±9.0 | 72.6±9.3 | 13.9±12.6 | 1.3±0.5 | -- |
Group | TPF (%) | FP/case | DC (%) | JI (%) | VER (%) | ASD (mm) | TBE (%) |
---|---|---|---|---|---|---|---|
79 tumors (n=14 ) | 100.0 | 3.1 | 74.1±16.9 | 70.9±17.7 | 12.4±12.0 | 1.6±1.5 | 0.9±1.0 |
10 MICCAI tumors (n=4) | -- | -- | 75.4±9.0 | 72.6±9.3 | 13.9±12.6 | 1.3±0.5 | -- |